Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Berthaud

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|October 16, 1999
[Bisphosphonates and bone metastases]A Lortholary, E Jadaud, P Berthaud
Lancet (London, England)|June 30, 1990
Effectiveness of interleukin-2 in invasive lymphoepithelial thymomaP Berthaud, T Le Chevalier, T Tursz
Bulletin Du Cancer|May 1, 1993
[Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors]P Berthaud, I Eugène-Jolchine, M Spielmann, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2007
Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumoursF Pein, R Pinkerton, P Berthaud, et al.
Revue Des Maladies Respiratoires|January 1, 1988
[Estimation of pulmonary dust load using magnetic pneumography]V Le Gros, D Lemaigre, C Suon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancerP Berthaud, T Le Chevalier, P Ruffie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancerC Monnerat, R Henriksson, T Le Chevalier, et al.
Optics Letters|January 15, 2005
Time-resolved measurements from speckle interferometryJ M Tualle, H L Nghiêm, C Schäfauer, et al.
Journal of Endocrinological Investigation|September 1, 1990
Hypothyroidism and goiter during interleukin-2 therapyP Berthaud, M Schlumberger, E Comoy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2000
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environmentS Derenne, M Amiot, S Barillé, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|October 16, 1999
[Bisphosphonates and bone metastases]A Lortholary, E Jadaud, P Berthaud
Lancet (London, England)|June 30, 1990
Effectiveness of interleukin-2 in invasive lymphoepithelial thymomaP Berthaud, T Le Chevalier, T Tursz
Bulletin Du Cancer|May 1, 1993
[Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors]P Berthaud, I Eugène-Jolchine, M Spielmann, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2007
Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumoursF Pein, R Pinkerton, P Berthaud, et al.
Revue Des Maladies Respiratoires|January 1, 1988
[Estimation of pulmonary dust load using magnetic pneumography]V Le Gros, D Lemaigre, C Suon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancerP Berthaud, T Le Chevalier, P Ruffie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancerC Monnerat, R Henriksson, T Le Chevalier, et al.
Optics Letters|January 15, 2005
Time-resolved measurements from speckle interferometryJ M Tualle, H L Nghiêm, C Schäfauer, et al.
Journal of Endocrinological Investigation|September 1, 1990
Hypothyroidism and goiter during interleukin-2 therapyP Berthaud, M Schlumberger, E Comoy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2000
Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environmentS Derenne, M Amiot, S Barillé, et al.
Pageof 3